Abstract
Liposomal drug delivery systems (LDDS) have emerged as a highly effective approach to improve the therapeutic potential of a variety of drugs. These nanoscale vesicular structures have the ability to encapsulate both hydrophilic and hydrophobic drugs, enhancing their bioavailability, stability, and therapeutic efficacy. This review article provides a comprehensive overview of the current trends in liposomal drug delivery, focusing on recent advancements, challenges, and future perspectives. The use of liposomes for targeted drug delivery, controlled release, and site-specific therapy in various diseases such as cancer, infection, and inflammatory disorders is discussed. Additionally, the paper highlights ongoing research in overcoming the limitations of LDDS, including stability issues and the scaling-up process for commercial production.

This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2020 Dr. Ayesha Khan (Author)